Prot# FVF3689g: A Phase IIIb, Multicenter Study to Evaluate the Safety and Tolerability of Ranibizumab in Naïve and Previously Treated Subjects with Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/0612/1/09

Funding

  • Genentech, Inc. (FVF3689g)